RealSelf, the leading online aesthetic educational and review portal, has unveiled its 2019 ‘Worth It’ ranking list, which reveals that two CynoSure treatments – the Mona Lisa Touch (MLT) and SculpSure – have been ranked among the top 15 most ‘Worth It’ non-surgical treatments. SculpSure and the MLT both scored an impressive 94% in the ‘Worth It’ ranking, which is based on reviews from RealSelf users who rank over 140 surgical and nonsurgical cosmetic procedures and brands, based on their personal experiences. SculpSure was the highest ranked non-surgical body shaping treatment, with MLT ranking as the second highest vaginal rejuvenation treatment.
"The RealSelf Worth It Rating is like getting instant advice from hundreds or thousands of friends who have had the exact treatment you're thinking about," said RealSelf founder and CEO Tom Seery. "Through the Worth It Rating, as well as photos and reviews, our community offers information that's not available anywhere else."
To be recognized as a "Most Worth It" procedure, a treatment must have a cumulative Worth It Rating of 90 percent or more over the prior 12 months and meet the minimum review requirement during the same period.
“We are delighted to see the positive real patient experiences of our treatments being reflected in these RealSelf rankings,” says Fiona Comport, UK Marketing Manager for CynoSure UK. “We hope these reviews give consumers the confidence to move forward with treatments, armed not just with the reassurance of our clinical and manufacturing heritage, but with real patients’ experiences!”
- ENDS -
Established in 1991, Cynosure consolidated its medical aesthetic device portfolio with several key acquisitions of Palomar, Con Bio and Ellman during the last decade. Cynosure means ‘a person or thing that is the centre of attention or admiration’ and the company prides itself on its products being the pinnacle of those available for its customer to ensure it lives up to this admiration. Cynosure itself was then acquired in 2017 by Hologic Inc, the USA’s leading developer and supplier of premium diagnostic products and medical imaging systems for breast and skeletal health, and GYN surgical products. With Cynosure now becoming the 4th division of this scientific driven company, the support and investment into on-going development and improvement of its product portfolio is secured. The UK team has a nationwide clinical training team, as well as 5 sales reps that operate up and down the UK, in specific territory splits.
For more information, please contact:
0207 969 1412